fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Minocycline HCL

All products: general benefit

Minocycline · DIN 02084104 · 100 mg · capsule

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Minocycline · DIN 02084104 Manufacturer: A A Pharma Inc.; listing date 2008-01-15 Health Canada: Marketed since 2020-01-03 · brand MINOCYCLINE · ATC J01AA08 MINOCYCLINE · form Capsule · route Oral · ingredients MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) 100 MG · company Aa pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Minocycline: Formulary list price $1.08 per unit (the source does not state the unit; exact figure $1.0836). What the ministry pays, not the patient.

Ministry pays: $1.0836 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02084104)

Source record
DIN 02084104: Minocycline Raw flags: sec3=Y Item: 081224022; group id 33; item number 0069; lccId None; manufacturer id AAP Source form: Cap; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $1.0836; ministry $1.0836 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02084104 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15925
Interchangeable products
Minocin · DIN 02173506 · not recorded
Shortage status: active shortage (reported September 29, 2026, estimated to end November 13, 2026, last updated October 2, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02084104
Shortage record checked October 6, 2026

Other products in the same Health Canada class (J01AA): coverage varies; not interchangeable

  • Doxycycline hyclate (PMS-Doxycycline): general benefit, not a benefit
  • Tetracycline (Tetracyn): general benefit, not a benefit
  • Tigecycline (Tygacil): general benefit
  • Doxycycline (Apprilon): not a benefit
Other drugs in the same formulary class (08:12:24 Tetracyclines) and how they are covered

Matched class: 08:12:24 Tetracyclines

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: TIGECYCLINE Some products covered without a code (check the product listing): DOXYCYCLINE HYCLATE, TETRACYCLINE 08:12:24 Tetracyclines

DOXYCYCLINE HYCLATE

· 11 products · Off-Formulary Interchangeable, not an ODB benefit (2), Listed, not a benefit (1), General benefit (8) · strengths: 20mg, 100mg · Cap, Tab

TETRACYCLINE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 250mg · Cap

TIGECYCLINE

· 1 products · General benefit · strengths: 50mg/Vial · Pd for Inj-5mLVial Pk (Preservative-Free)

DOXYCYCLINE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 40mg · MR Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 08:12:24
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATION AND CLINICAL USES MINOCYCLINE (minocycline hydrochloride) may be indicated for the treatment of the following infections due to susceptible strains of the designated organisms: Gall bladder infections caused by Escherichia coli. Urinary tract infections: cystitis, gonorrhea, pyelonephritis caused by Escherichia coli, Proteus species, Klebsiella species, Enterobacter aerogenes, Neisseria gonorrhoeae. When penicillin is contraindicated, minocycline may be employed as an alternative drug in the treatment of anal and pharyngeal gonorrhea and syphilis. Skin and soft tissue infections: abscess, cellulitis, furunculosis, impetigo and pyoderma caused by: Staphylococcus epidermidis. Staphylococcus aureus, Streptococcus pyogenes, Proteus Page 2 of 30 species, Escherichia coli. Although tetracyclines are not the drugs of choice in any staphylococcal or streptococcal infection minocycline could be useful in circumstances where these organisms are shown to be resistant to other agents but sensitive to minocycline. Bacterial evaluation of clinical cases invo… https://pdf.hres.ca/dpd_pm/00053334.PDF PM date: September 27, 2019 Source product: MINOCYCLINE; DIN 02084090; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Minocycline · DIN 02084104 Shortage status: active shortage (reported 2026-09-29, estimated to end 2026-11-13, last updated 2026-10-02); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02084104

Check this DIN again